Prevalence of EML4-ALK Fusion Gene in Adenocarcinoma Lung Patients by Using Immuno Histo Chemistry

被引：0
|
作者：
Talwar, V. [1 ]
机构：
[1] Rajiv Gandhi Canc Hosp & Inst, Med Oncol, Delhi, India
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 09期
关键词：
EML4-ALK Immuno histo chemistry;
D O I：
10.1016/j.jtho.2018.07.054
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P15
引用
收藏
页码：S167 / S167
页数：1
相关论文
共 50 条
  • [31] Evidence that the Lung Adenocarcinoma EML4-ALK Fusion Gene Is not Caused by Exposure to Secondhand Tobacco Smoke During Childhood
    Ryan, Brid M.
    Wang, Yi
    Jen, Jin
    Yi, Eunhee S.
    Olivo-Marston, Susan
    Yang, Ping
    Harris, Curtis C.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (07) : 1432 - 1434
  • [32] Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively
    Hong Tao
    Zhe Liu
    Jing Mu
    Fei Gai
    Zhan Huang
    Liang Shi
    Diagnostic Pathology, 17
  • [33] Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively
    Tao, Hong
    Liu, Zhe
    Mu, Jing
    Gai, Fei
    Huang, Zhan
    Shi, Liang
    DIAGNOSTIC PATHOLOGY, 2022, 17 (01)
  • [34] Novel NLRC4-ALK and EML4-ALK double fusion mutations in a lung adenocarcinoma patient: A case report
    Wu, Xueqian
    Wang, Weiya
    Zou, Bingwen
    Li, Yanying
    Yang, Xiaojuan
    Liu, Ning
    Ma, Qizhi
    Zhang, Xiaoxuan
    Wang, Yongsheng
    Li, Dan
    THORACIC CANCER, 2020, 11 (06) : 1695 - 1698
  • [35] ALK inactivation induced acquired resistance to alectinib in lung cancer harboring EML4-ALK fusion gene
    Isozaki, Hideko
    Ichihara, Eiki
    Yasugi, Masayuki
    Nobuaki, Ochi
    Hotta, Katsuyuki
    Takigawa, Nagio
    Sendo, Toshiaki
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    CANCER RESEARCH, 2014, 74 (19)
  • [36] EML4-ALK fusion lung cancer:: A rare acquired event
    Perner, Sven
    Wagner, Patrick L.
    Demichelis, Francesca
    Mehra, Rohit
    LaFargue, Chris J.
    Moss, Benjamin J.
    Arbogast, Stefanie
    Soltermann, Alex
    Weder, Walter
    Giordano, Thomas J.
    Beer, David G.
    Rickman, David S.
    Chinnaiyan, Arul M.
    Moch, Holger
    Rubin, Mark A.
    NEOPLASIA, 2008, 10 (03): : 298 - 302
  • [37] Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma
    Wang, Qiushi
    Yang, Xin
    He, Yong
    Ma, Qiang
    Lin, Li
    Fu, Ping
    Xiao, Hualiang
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (05): : 515 - 520
  • [38] EML4-ALK Fusion Gene in Korean Non-Small Cell Lung Cancer
    Jin, Guang
    Jeon, Hyo-Sung
    Lee, Eung Bae
    Kang, Hyo-Gyoung
    Yoo, Seung Soo
    Lee, Shin Yup
    Lee, Jae Hee
    Cha, Sung Ick
    Park, Tae In
    Kim, Chang Ho
    Jheon, Sang Hoon
    Park, Jae Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (02) : 228 - 230
  • [39] EML4-ALK fusion gene in resected non-small-cell lung cancer
    Takahashi, Tsuyoshi
    Sonobe, Makoto
    Menju, Toshi
    Nakayama, Ei
    Mino, Nobuya
    Iwakiri, Shotaro
    Sato, Kiyoshi
    Miyahara, Ryo
    Okubo, Kenichi
    Date, Hiroshi
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S483 - S484
  • [40] Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung
    Doval, D. C.
    Prabhash, K.
    Patil, S.
    Chaturvedi, H.
    Goswami, C.
    Vaid, A. K.
    Desai, S.
    Dutt, S.
    Veldore, V. H.
    Jambhekar, N.
    Mehta, A.
    Hazarika, D.
    Azam, S.
    Gawande, S.
    Gupta, S.
    ONCOTARGETS AND THERAPY, 2015, 8 : 117 - 123
12345